Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and md 780236

3,4-dihydroxyphenylacetic acid has been researched along with md 780236 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fuller, RW; Hemrick-Luecke, SK	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and md 780236

Article	Year
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Life sciences, 1985, Sep-23, Volume: 37, Issue:12 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Harmaline; Homovanillic Acid; Male; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Oxidation-Reduction; Pyridines	1985

Article

Year

Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

Life sciences, 1985, Sep-23, Volume: 37, Issue:12

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Harmaline; Homovanillic Acid; Male; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Oxidation-Reduction; Pyridines

1985